Compare US Global Jets ETF (JETS) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
US Global Jets ETF vs Revvity Inc — how do they compare? US Global Jets ETF trades at $31.64, while Revvity Inc trades at $116.27 (market cap $12.91B). The key difference: Revvity Inc pays a 0.24% dividend while US Global Jets ETF pays none, and Revvity Inc is trading nearer its 52-week high, US Global Jets ETF nearer its low. Which is the better fit depends on your goals.
| JETS | RVTY | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $33.53 | $117.75 |
52-Week Low | $23.64 | $82.26 |
Market Cap | — | $12.91B |
Enterprise Value | — | $15.23B |
Dividend Yield | — | 0.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JETS trades at $31.63, up 0.6% on the day, with a bullish technical signal from moving averages but neutral oscillators. Recent news highlights airline earnings beats and government rebates for plane retrofits, though fuel cost volatility remains a headwind. The ETF focuses on U.S. airline operators, offering exposure to travel demand but facing cyclical risks.
Outlook is mixed: lower oil prices support profitability, but geopolitical tensions and fuel swings pose risks. JETS provides diversified airline exposure but underperforms defense-focused peers on expense ratios and drawdowns. Investor sentiment is cautious amid earnings revisions and sector comparisons.
RVTY trades at $116.10, up 0.07% on the day, with a bullish technical signal and strong earnings beats in recent quarters. The company reported Q2 2026 EPS of $1.41, surpassing the $1.21 estimate, and raised its full-year outlook due to robust diagnostics demand. Revenue remains steady around $2.9 billion, with a net income margin of 8.16%. Analyst consensus is a Buy with a $120.50 price target, and recent news highlights product launches like the SuperFlex prenatal system and high-throughput TB testing platform.
The outlook for RVTY is positive, supported by earnings momentum and strategic innovations, but investors face risks from high valuation multiples and competitive pressures in the healthcare sector. The stock's proximity to its consensus target suggests limited near-term upside, requiring careful monitoring of execution against raised guidance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About US Global Jets ETF
JETS provides targeted exposure to the global airline industry, including commercial airlines, aircraft manufacturers, and airport operators. It focuses on major U.S. and international carriers like Delta, United, and American Airlines.
Read more on JETS →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
